Kazunori Nishi

This inventor holds 15 USPTO granted patents, primarily in G Protein-Coupled Receptors. Top assignees: Takeda Chemical Industries, Inc., Takeda Pharmaceutical Company Limited. Active years: 1999-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazunori Nishi. Retrieved from https://idiyas.com/inventor/kazunori-nishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 46.7

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 25(Granted Patents)

Location History:

London, GB (2004 - 2008)
Ibaraki, JP (1999 - 2011)
Tsukuba, JP (1999 - 2011)

Company Filing History:

8 out of 1,858

Takeda Chemical Industries, Inc.

patents

7 out of 1,229

Takeda Pharmaceutical Company Limited

patents

Years Active: 1999-2011

Loading Chart...

Areas of Expertise:

G Protein-Coupled Receptors

FPRL1 Ligands

Insulin Polypeptides

Tachykinin-Like Polypeptides

Screening Methods

Polypeptide Production

DNA Techniques

Glutamine Metabolism

Human CRM1 Protein

Fas Ligand-Like Protein

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7943137 - FPRL1 ligands and use thereof (2011-05-17),

2. 7927821 - Methods of screening for compounds which bind G protein-coupled receptors (2011-04-19),

3. 7892755 - Screening method (2011-02-22),

4. 7781175 - Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid (2010-08-24),

5. 7410641 - Antibodies to insulin/IGF/relaxin family polypeptides (2008-08-12),

6. 7235531 - Tachykinin-like polypeptides and use thereof (2007-06-26),

7. 7049403 - Insulin/IGF/relaxin family polypeptides and DNAS thereof (2006-05-23),

8. 6797483 - Polypeptide and DNA thereof (2004-09-28),

9. 6632627 - Glutamine: fructose-6-phosphate amidotransferase, its production and use (2003-10-14),

10. 6590090 - Fas ligand-like protein, its production and use (2003-07-08),

11. 6235878 - Fas ligand-like protein, its production and use (2001-05-22),

12. 6207431 - Glutamine:fructose-6-phosphate amidotransferase, its production and use (2001-03-27),

13. 6068990 - Proteins, their production and use (2000-05-30),

14. 5948883 - Human CRM1 Protein (1999-09-07),

15. 5874277 - Proteins, their production and use (1999-02-23),

Title: Kazunori Nishi: Innovator in G Protein-Coupled Receptor Research

Introduction

Kazunori Nishi is a prominent inventor based in London, GB. He has made significant contributions to the field of biochemistry, particularly in the area of G protein-coupled receptors. With a total of 15 patents to his name, Nishi's work has the potential to impact various medical conditions.

Latest Patents

Nishi's latest patents include innovative methods and compounds that target FPRL1 ligands. One of his notable inventions involves using FPRL1 ligands that share amino acid sequences with specific SEQ ID numbers. This invention allows for efficient screening of FPRL1 agonists or antagonists. Another significant patent focuses on screening methods for compounds that bind to G protein-coupled receptors. This method is crucial for identifying agents that can prevent or treat a range of diseases, including leukemia, rheumatoid arthritis, and metabolic syndrome.

Career Highlights

Throughout his career, Kazunori Nishi has worked with esteemed organizations such as Takeda Chemical Industries, Inc. and Takeda Pharmaceutical Company Limited. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Nishi has collaborated with notable colleagues, including Yasushi Shintani and Yukiko Hikichi. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kazunori Nishi's contributions to the field of biochemistry and his innovative patents in G protein-coupled receptor research highlight his importance as an inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]